Edward Alveyn
About
In The Last Decade
Edward Alveyn
14 papers receiving 167 citations
Hit Papers
Peers
Comparison fields: 5 of 57
- Rheumatology 59
- Immunology 37
- Oncology 33
- Artificial Intelligence 31
- Radiology, Nuclear Medicine and Imaging 29
Countries citing papers authored by Edward Alveyn
This map shows the geographic impact of Edward Alveyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Alveyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Alveyn more than expected).
Fields of papers citing papers by Edward Alveyn
This network shows the impact of papers produced by Edward Alveyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Alveyn. The network helps show where Edward Alveyn may publish in the future.
Co-authorship network of co-authors of Edward Alveyn
This figure shows the co-authorship network connecting the top 25 collaborators of Edward Alveyn. A scholar is included among the top collaborators of Edward Alveyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Alveyn. Edward Alveyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 0 | |
| 8 | 1 | |
| 9 | 0 | |
| 10 | JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications breakdown → | 75 |
| 11 | 3 | |
| 12 | 4 | |
| 13 | 0 | |
| 14 | 0 | |
| 15 | 13 | |
| 16 | 1 | |
| 17 | 1 | |
| 18 | 2 | |
| 19 | 2 | |
| 20 | 53 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.